Ibnsina Pharma
CASE:ISPH
£ 10,16
+ £0,46 (4,74%)
10,16 £
+£0,46 (4,74%)
End-of-day quote: 04/01/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

£0,30
Earnings Per Share
£55,40
Revenue Per Share
7,87%
Gross Margin %
£9,78 B
Market Cap
£0,89 B
Long-Term Debt
Earnings Per Share
£0,30
Revenue Per Share
£55,40
Gross Margin %
7,87%
Market Cap
£9,78 B
Long-Term Debt
£0,89 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020
EPS Earnings Per Share £0,76 £0,49 £0,17 £0,13 £0,22 £0,16
Earnings Earnings £766,08M £493,92M £171,36M £131,04M £269,73M £179,20M
RPS Revenue Per Share £0,00 £75,99 £55,40 £33,68 £22,09 £17,73 £16,68
Revenue Revenue £0,00M £76,60B £55,84B £33,95B £22,26B £21,73B £18,68B
OCF Operating Cash Flow £0,00M £1,51B £-926,58M £125,81M £361,94M £-340,43M £588,07M
FCF Free Cash Flow £0,00M £941,00M £-1,18B £-228,23M £0,00M £-487,96M £357,94M
OM Operating Margin 0,00% 4,62% 4,04% 3,39% 2,17% 3,07% 2,62%
GM % Gross Margin % 0,00% 8,42% 7,87% 7,41% 7,26% 7,50% 7,85%
FCFS Free Cash Flow Per Share £0,00 £-0,84 £-1,20 £-0,23 £-0,46 £-0,38 £0,02
LT Debt Long-Term Debt N/A £891,23M £47,46M £556,02M £852,18M £204,83M £405,68M
Sha. Stocks 1.008M 1.008M 1.008M 1.008M 1.008M 1.226,04M 1.119,99M
×